Farid Ramy — SEC Form 4 filings
SEC reporting owner CIK 1797707. 8 Form 4 filings on record with FilingPulse; latest filed 2026-05-28.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-03-05 to 2026-05-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 3 filings — 95,221 shares, $1,168,577 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 43,000 shares @ $12.33 ($530,233) in Schrodinger, Inc., filed 2026-04-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Schrodinger, Inc. (SDGR) | President & CEO, Director | 5 | — | 4 legs · 95,221 sh · $1,168,577 | 15 |
| Vir Biotechnology, Inc. (VIR) | Director | 3 | — | — | 7 |
Form 4 filings — Farid Ramy
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-28 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 8,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2026-04-17 | 4 | Schrodinger, Inc. (SDGR) | Option exercise (M): 43,000 @ $3.07 · Sale (S): 43,000 @ $12.33 · Option exercise (M): 43,000 @ $3.07 · Sale (S): 43,000 @ $12.21 · Option exercise (M): 74,527 @ $3.07 · Option exercise (M): 43,000 (derivative) @ $0 · +2 more | EDGAR |
| 2026-03-06 | 4 | Schrodinger, Inc. (SDGR) | Sale (S): 3,661 @ $12.91 | EDGAR |
| 2026-03-03 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 56,250 @ $0 · Grant/award (A): 13,604 @ $0 · Grant/award (A): 48,259 @ $0 · Sale (S): 5,560 @ $11.90 · Grant/award (A): 112,500 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 8,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 37,500 @ $0 · Grant/award (A): 60,000 (derivative) @ $0 · Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2024-05-31 | 4 | Vir Biotechnology, Inc. (VIR) | Grant/award (A): 16,000 @ $0 · Grant/award (A): 16,000 (derivative) @ $0 · Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | Schrodinger, Inc. (SDGR) | Grant/award (A): 126,000 (derivative) @ $0 · Grant/award (A): 87,271 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1797707 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →